Performance
Trailing returns
| 1 day | +1.67% |
| |||
| 1 week | +1.67% |
| |||
| 4 week | +3.87% |
| |||
| 3 month | +6.43% |
| |||
| YTD | +15.33% |
| |||
| 1 year | +26.88% |
| |||
| 3 years* | +10.98% |
| |||
| 5 years* | +6.82% |
| |||
| *annualized | |||||
Morningstar statistics
Morningstar category: GBP Flexible Allocation
| Return | Risk | Rating | |
| 3 years | Above Average | High |
 
|
| 5 years | Above Average | High |
|
| 10 years | - | - | - |
| Overall | Above Average | High |
|
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | ||
| Front load | 7.50% | |
| Deferred load | - | |
| Expense ratio | - | |
| Management fee | 1.18% | |
| Fund family | Aberdeen Asset Mgt,Eden (Capita) |
Asset allocation
| Cash | 1.43% | |
| Stocks | 97.94% | |
| Bonds | 0.00% | |
| Preferred | 0.56% | |
| Other | 0.07% |
Purchase information
| Initial | �100,000 | |
| Additional | �0 | |
| AIP Initial | �0 | |
| AIP Additional | �0 |
0.000.00(0.00%)
May 20, 4:00PM GMT+1
Overall Morningstar RatingTM
Description
This investment objective of the CF Greenmount Fund is to achieve a combination of capital growth and income from an internationally diversified portfolio of equities and bonds although; income will be of secondary importance. There will not be any restrictions as to industrial, economic or geographical sectors. The investment objective of the CF Greenmount Fund is to achieve a combination of capital growth and income from an internationally diversified portfolio of equities, bonds, Government securities, collective investment schemes and money market instruments although income will be of secondary importance. There may be occasions when the investment manager chooses to hold a high level of cash. There will not be any restrictions as to industrial, economic or geographical sectors.
Advisor Company:
Aberdeen Asset Managers Ltd (London)
Aberdeen Asset Managers Ltd (London)
Aberdeen Asset Mgt,Eden (Capita)
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | -9.92 | -8.42 | -3.84 | - | |
| Beta* | 1.88 | 2.00 | 1.60 | - | |
| Mean annual return | 1.38 | 0.76 | 0.70 | - | |
| R-squared* | 53.08 | 59.13 | 66.36 | - | |
| Standard deviation | 9.21 | 14.41 | 18.99 | - | |
| Sharpe ratio | 1.73 | 0.59 | 0.37 | - | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| Aberdeen Global Emerging Markets Eq A2 | 13.28% | |
| Roche Holding AG (RHHVF) | 3.95% | |
| Taiwan Semiconductor Manufacturing ADR (TSM) | 3.48% | |
| British American Tobacco PLC (BATS) | 3.06% | |
| Johnson & Johnson (JNJ) | 3.04% | |
| Vodafone Group PLC (VODPF) | 3.04% | |
| Standard Chartered PLC (STAN) | 3.04% | |
| Zurich Insurance Group AG (ZFSVF) | 2.98% | |
| Novartis AG (NVSEF) | 2.79% | |
| Philip Morris International, Inc. (PM) | 2.69% |